Article
Repurposing celecoxib for ovarian cancer treatment by targeting survivin signaling
2023-01-06
Abstract excerpt
<title>Abstract</title> <p>Background Ovarian cancer is the leading cause of deaths among gynecologic cancers. With a five-year survival rate just slightly above 45% and high rates of chemo-toxicity and chemo-resistance, the search for novel, more effective, and less toxic therapeutic approaches is thus imperative. In the current study, we aimed to explore the potential antitumor effect of a COX-2 inhibitor, cel...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- eacebb04-652d-554b-892f-169d35c6391f
- DOI
- 10.21203/rs.3.rs-2429733/v1
